Avanos Medical (AVNS) Liabilities from Discontinued Operations (2016 - 2024)

Avanos Medical has disclosed Liabilities from Discontinued Operations across 6 years of filings, most recently posting 52900000.0 for Q3 2024.

• Liabilities from Discontinued Operations for Q3 2024 came in at 52900000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was 52900000.0 (changed N/A YoY), and the FY2023 annual result was 63700000.0, up 797.18% from the prior year.
• Liabilities from Discontinued Operations came in at 52900000.0 for Q3 2024 at Avanos Medical, roughly flat from 52700000.0 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of 63700000.0 in Q4 2023 to a low of 2700000.0 in Q2 2023.
• The 3-year median for Liabilities from Discontinued Operations is 52450000.0 (2024), against an average of 38550000.0.
• Across the five-year window, Liabilities from Discontinued Operations soared 797.18% in 2023 and soared 1851.85% in 2024, its largest moves.
• Avanos Medical's Liabilities from Discontinued Operations stood at 7100000.0 in 2022, then jumped by 797.18% to 63700000.0 in 2023, then fell by 16.95% to 52900000.0 in 2024.
• The last three Liabilities from Discontinued Operations figures came in at 52900000.0 (Q3 2024), 52700000.0 (Q2 2024), and 52200000.0 (Q1 2024), per Business Quant data.